To ensure the captured cells were truly tumor cells, we performed single cell analyses, which included whole-genome amplification, followed by the detection of mutations in the KRAS, BRAF, and PIK3CA genes, which are alterations representative of CRC [16]. The gene discussed is KRAS; the disease is colorectal carcinoma.